In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Could Elekta's mystery new product help it grab market share from rival Varian?

This article was originally published in Clinica

Executive Summary

Radiotherapy specialist Elekta will be launching a new product that it describes as "the future of radiotherapy" on 1 March, prompting excitement among analysts. "While the company has yet to provide details about the new system, our due diligence suggests that it will likely be a state-of-the-art IGRT [image-guided radiotherapy] system, focused on the higher-end part of the market, and competitive vs [Varian Medical Systems'] TrueBeam," wrote Goldman Sachs' Veronika Dubajova.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts